gp330, a large glycoprotein located in renal proximal tubules, has sequence similarities with the low-density lipoprotein receptor and the a2-macroglobulin receptorllow-density lipoprotein receptor-related protein. The 40 KD human azmacroglobulin receptor-associated protein is a newly discovered heparin binding protein homologous to a major rat Heymann nephritis factor and exhibiting high affinity binding to the a2-macroglobulin receptor. The present study shows by ligand blotting, light and electron microscopic autoradiography, and cytochemistry that gp330 located in coated apical membrane regions of the rat proximal tubule strongly binds the 40 KD protein. Furthermore, 45Ca2+ blotting experiments disdosed gp330 as a quantitatively important Ca2+ binding protein in renal cortex. Binding of '251-labeled 40 KD protein to electroblotted gp330 and to coated apical membrane regions in sections of renal proximal tubules was 40:1481-1490, 1992) KEY WORDS: Rat renal proximal tubule; Immunocytochemistry; Autoradiography on cryosections; 40 KD a2-macroglobulin-associated protein; Receptor-mediated endocytosis; Heymann nephritis antigen.
Introduction
gp330 was identified by Kerjaschki and Farquhar (12, 13) as a putative antigen causing Heymann nephritis, a rat model of human idiopathic membranous glomerulonephritis. This protein, whose normal function is unknown, is localized in coated apical invaginations of rat renal proximal tubule cells and in the plasma membrane of glomerular podocytes (15). Partial cloning and sequencing (26) have demonstrated that gp330 belongs to the same gene family as the low-density lipoprotein receptor (LDLR) and the a2macroglobulin receptor (u~MR), also known (9) as low-density lipoprotein receptor-related protein (LRP). Tyrosine-containing C-terminal sequences of gp330 are highly homologous to sequences in the intracellular C-terminal part of LDLR known to be important for endocytosis (26) . This suggested that gp330 might be a receptor for endocytosis.
The human a2MR-associated protein ( abolished by ex-unlabeled 40 KD protein, heparin, and EDTA. The endocytic properties of gp330 were investigated by in vivo microperfusion of rat proximal tubules. After 6 min, 12SI-labeled 40 KD protein was mainly found in endocytic vacuoles and later accumulated in lysosomes. These data demonstrate that gp330 is a Ca2+ binding receptor for endocytosis of protein and is functionally related to the a2macroglobulin receptorllow-density lipoprotein receptorrelated protein. Furthermore, our results demonstrate the usefulness of semi-thin and ultra-thin ayosections in studies of ligand binding and subcellular localization of receptors with autoradiographic techniques. (JHistochem Cytochem found as a 40 KD (10) or 39 KD (1) component of a2MRILRP preparations purified by affinity chromatography with immobilized receptor-active a2M. It is a gene product separate from a2MRILRP (16, 28) and exhibits high-affinity, heparin-inhibitable binding to a2MRILRP (22) . Recent cloning and sequencing (27) demonstrated that azMRAP is a human homologue of the mouse heparin binding protein HBP44 (5) and a rat protein sequence (25), here referred to as a2MRAP, originally thought to be part of gp330. When injected, rat recombinant a2MRAP causes subepithelial immune deposits in glomeruli as seen in active Heymann nephritis in rats (25). Taken together, these results suggested that a2MRAP might be a ligand to rather than part of gp330. Here we show strong Ca2'dependent and heparin-inhibitable binding of human a2MRAP to rat gp330. Moreover, microperfusion of rat proximal tubules in vivo followed by light and electron microscopic autoradiography demonstrate gp330-mediated endocytosis of a2MRAP.
Materials and Methods
Animals and Fixation. Male Wistar rats, 225-250 g, were used for all Antibodies. Rabbit polyclonal antibody against rat gp330 was kindly experiments. provided by Dr. D. Kerjaschki and Dr. M.G. Farquhar. Monoclonal antibodies (MAb) against rat gp330 (K35l9) and a 107 KD brush-border protein (K3514) were kindly provided by Dr. D.L. Mendrick and have been described previously (21) . The MAb and a rabbit polyclonal antibody against a2MRlLRP were raised against human protein (22.23); immunoblot analysis demonstrated reaction with these MAb (A2MRa-1 and A2MRp-1) and the polyclonal antibody with rat liver a2MRlLRP (data not shown).
Immuno-and Ligand Blotring. Rat renal cortex (100 mg) was homogenized and solubilized in 1 ml 1% Triton X-100 in 20 mM Tris, 150 mM NaCI. and 1 mM phcnylmethanosulphonylfluoride and centrifuged for 2 min in an Eppendorf microcentrifuge. Twenty p1 of the supernatant were mixed with 20 pI of a non-reducing sample buffer containing 5 % SDS and this solution was applied to a sodium dodecyl sulfate gel with a 4-16% polyacrylamide gradient. electroblotted for 1.5 hr onto an Immobilon filter (Millipore. Bedford. MA). The filter was blocked for 2 hr in 2% non-fat dry milk, incubated for 2 hr with primary antibody diluted 1:1000 in 0.2% non-fat dry milk, washed three times for I5 min in PBS with 0.05 % Tween-20. incubated with alkaline phosphatase-conjugated secondary antibody (Dakopatts; Glostrup. Denmark) diluted 1:lOOO in 0.2% non-fat dry milk, washed. and finally incubated with 5-bromo-4-chloroindolyl-phosphate (0.125 mglml) and Nitroblue tetrazolium (0.25 mglml) as substrate.
Blotting with 4'Ca2' (RiM; Roskildc, Denmark) was carried out as described (18) . Ligand blotting with ['2'I]-a2MRAP was carried out as follows: filters with electroblotted renal cortex protein were blocked for 2 hr in 2% bovine serum albumin and 0.05% Tween-20 in PBS. incubated with 5 x 10' cpm [I2'I]-a2MRAP for 2 hr at room temperature. washed three times for 5 min in 0.05% Tween-20 in PBS, dried. and exposed to Amersham Hyperfilm (Poole. UK) for 24 hr. a2MRAP was purified from placental. a2MRlLRP preparation (22). Approximately 1 mg protein in 20 mM NaH2P04. pH 7.4. and 0.5% CHAPS was loaded onto a 5-ml heparin-Sepharose column. a2MRAP was eluted by raising the NaCl concentration to 2 M. The eluted material was iodinated as described (22). Pure [ I2'I]-a2MRAP was obtained by S-200 gel filtration. The specific activity was about 0.15 Cilpnol.
Immunohisto-and Cytochemistry. Rats were fixed by retrograde perfusion through the abdominal aorta with 8% paraformaldehyde in 0.15 M sodium cacodylate buffer, pH 7.2, further fixed by immersion with the same fixative for 1 hr. infiltrated with 2.3 M sucrose containing 2% paraformaldehyde for 30 min, and frozen in liquid nitrogen. Sections were obtained by cryoultramicrotomy with a Reichert-Jung FC 4D cryoultramicrotome at 160-180 K. For light microscopy, 0.80-pm sections were placed on gelatin-coated glass slides. For electron microscopy 70-90-nm sections were placed on 300-mesh Ni grids. All sections were pre-incubated in PBS containing 0.1% non-fat dry milk and 0.05 M glycine.
For immunolabeling, the sections were then incubated with the primary antibody either for 1 hr at room temperature or at 4°C overnight at different dilutions (see Results) in the same buffer as a h but without glycine, and then washed in the same buffer. For light microscopy the sections were incubated with peroxidase-conjugated rabbit anti-mow immunoglobulins ( W R a M ) (Dakopam) or with peroxidase-conjugated goat anti-rabbit immunoglobulins (HRP-GaR) (Dakopatts). The peroxidase was visualized with diaminobenzidinc and the sections were then washed in PBS. For electron microscopy, the sections were incubated for 2 hr at 4'C with 10-nm protein A-gold Uanssen; Beene, Belgium). or with rabbit anti-mouse immunoglobulins (Dakopam) for 30 min at room temperature and then protein A-gold or, alternatively, directly with 5-nm gold particles conjugated to rabbit anti-mouse immunoglobulins (Amenham). The sections for electron microscopy were finally embedded in 2% methylcellulose containing 0.3% uranyl acetate according to Tokuyasu (29) as modified by Griffiths et al. (6) . The peroxidase-labeled sectionswere studied in a kits Orthoplane microscope, and the EM sections in a JEOL 100 CX electron microscope.
For immunolabeling, the following controls were performed: (a) with- out primary antibody; (b) without primary and secondary antibodies; and (c) with nonspecific antibodies. None of these controls showed any specific labeling.
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Light and Electron Microscopic Autoradiography with ['251]-Labelcd Ligand or 45Ca2'. For autoradiography, cryoscctions were incubated with [1251]-labeled a2MRAP protein (about 1 pCilml) either alone or together with different inhibitors at various concentrations diluted in a PBS buffer containing 0.1% BSA. Some sections were incubated with 4'Ca2'. The sections were then washed and subsequently fixed in 1% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.2, for 10 min and washed in PBS.
For light microscopic autoradiography, the sections were dipped in emulsion (LMl; Amenham), exposed for 1 day and up to 2 weeks. developed in Kodak D 19 developer. fixed in sodium thiosulfate, and subsequently stained in toluidine blue. For electron microscopic autoradiography the sections were embedded in 2% methylcellulose with 0.3% uranyl acetate as above and then coated with carbon. Autoradiographic emulsion (Ilford 4) was applied by a modified wire loop method (19). exposed for 1 week. dcveloped in Kodak D 19, and fixed in sodium thiosulfate. 
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Mimoperfusion Experiments. Male Wistar rats, about 225 g, fasted overnight were anesthetized by intraperitoneal injection of Inactin (150 mg/kg body weight) (Byk-Gulden; Konstanz, Germany) and placed on a thermostatically heated table. After tracheotomy a catheter was placed in the right jugular vein and the rat was infused with an 0.9% NaCl solution at a constant rate of 3.8 ml/hr. The left kidney was exposed by a flank incision, placed in a stabilized thermostatically heated cup, and covered with liquid paraffin. The perirenal temperature was maintained at 37-38°C. For electron microscopic autoradiographic studies, 20 nl PBS containing about 1 pCi/ml of ["'I]-a2MRAP was microinfused over 1 min with albumincoated calibrated glass pipettes, and the tubules were fixed from 6 to 25 min after start of the infusion with 1% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.2. Nine tubules in two rats were microinfused. Pyramids containing the microinfused tubules were cut from the kidneys, post-fiued in 1Yo Os04 in the same buffer, dehydrated in graded alcohols, and embedded in Epon 812 in flat molds. Sections for both light and electron microscopy were prepared for autoradiography as above.
To study whether the uptake of a2MRAP was saturable, 10 tubules in two rats were microinfused with [12'I]-a2MRAP and fixed after 6 min. Pyramids containing the microinfused tubules were then counted. Only tubules with at least two convolutions at the surface were used for these microinfusions. Since azMRAP was found to bind extensively to glassware and the concentration in the stock solution is low (about 6.5 x M), five of these tubules were microperfused with the same solution as above but with the addition of M cold a2MRAP and five tubules with the addition of M cold a2MRAP. responding to gp330, whereas the two anti-a2MRlLRP MAb (A2MRa-1 and A2MRS-1) did not react. In conclusion, these data demonstrate gp330 as an abundant high molecular weight Ca2+ binding protein in kidney cortex which binds a2MRAP in a calcium-dependent way. The immunolabeling of gp330 (Figure 2a ) was confined to a relatively narrow band in the apical part of the proximal tubule cells just below the brush border, as revealed by peroxidase. The labeling was seen in all segments of the proximal tubule, including the S3 segment. There was no labeling in other segments of the nephron. The MAb K 3514 against the 107 ~cD protein revealed a different pattern, showing a broad band of labeling in the proximal tubules corresponding to the brush border, illustrating that gp330 is not a brush-border protein but is confined to a region just below the brush border (compare Figures 2a and 2 b) . No tubule reaction was seen with the two MAb (A2MRa-1 and A2MRP-1) recognizing rat and human a2MRlLRP a-and P-chain. However, labeling was seen just below the brush border in renal proximal tubules with polyclonal anti-human a2MRlLRP. probably due to crossreactivity.
Results

Immzlno-and Ligand Blotting of Rat Kidney gp330
Light Microscopic Immunohistochemistry ana' Auto radiography
Ligand labeling with [ 1251]-a2MRAP followed by autoradiography (Figures 2c and 2d) showed intense staining of the apical part of the tubule cells in all segments of proximal tubules only, revealing the same distribution as shown for gp330 by immunohistochemistry. No labeling was seen on addition of 100 nM unlabeled a2MRAP, 5 mM of EDTA (Figures 2e and 2f) or heparin (250 Ulml) (not shown). No significant reduction of [ 12'I]-a2MRAP binding was observed on addition of the anti-gp330 antibodies used in the present study.
The very sensitive [ 12SI]-a2MRAP binding to the cryosections was utilized to test for inhibition by other proteins. Insulin, lysozyme, and cytochrome c, proteins known to be rapidly endocytosed in the proximal tubule (4), had no effect, in concentrations up to 20 pM, on the binding of [1251]-a2MRAP (data not shown). a2-Macroglobulin-methylamine, which interferes with a2MRAP binding to a2MRlLRP (24). did not inhibit either (data not shown). Plasminogen, newly reported to bind to gp 330 (11) , virtually inhibited binding at concentrations down to 0.7 pM (compare Figures  3a and 3b) .
Localization of Ca2+ binding proteins was studied by direct in- cubation of cryosections with 41Ca2+ followed by autoradiography. Apical labeling was seen just below the brush border, similar to the a2MRAP labeling, but in addition weak labeling was seen in the cytoplasm (Figure 3c ).
Eiectron Microscopic Immunocytochemistry and Autoradiography
The apical immunolabeling of gp330 was seen in proximal tubules in the apical endocytic invaginations and small endocytic vacuoles (Figures 4a and 4b ). In addition, there was a slight labeling of large endocytic vacuoles and dense apical tubules with the MAb K 3519 against gp 330. The brush border was not labeled and no other compartment in the cells appeared to be labeled. In contrast, the MAb 3514 against the 107 KD protein revealed heavy labeling of the brush border of the proximal tubule cells and there was no labeling of other compartments in the cells (Figure 4c ). Ligand labeling with [ 12'I]-a2MRAP on ultra-thin cryosections showed autoradiographic grains over coated invaginations, small endocytic vacuoles, and to a lesser extent over large endocytic vacuoles (Figure 5 ) .
Microperfusion Experiments
Light microscopic autoradiography showed labeling in the apical part of the proximal tubules in the nephron 15 min after start of microinfusion of [ 12'I]-a2MRAP ( Figure 6 ). However, several grains also appeared to be located deeper in the cells. As shown by electron microscopic autoradiography. after 6 min the grains were mainly found over endocytic invaginations and vacuoles (Figure 7a ). and later an accumulation of the a2MRAP protein was seen in the lysosomes (Figures 7b and 8 ).
The inhibition experiments showed that the tubule accumulation of radioactivity after 6 min was 45.2% t 6.6 (SEM) of the perfused amount at a concentration of a2MRAP protein in the perfusate of IO-' M, and at lo-' M the accumulation was 17.0% t 3.2 (SEM). This difference was highly significant (Zp<O.OOl) as shown by Student's t-test.
Discussion
The reabsorption of proteins in the renal proximal tubules is largely mediated by adsorptive endocytosis, and the specificity of the initial binding and uptake has been much debated, as recently reviewed (4.17.20) . The present study classifies for the first time gp330 as a receptor capable of mediating endocytosis from the luminal part of the renal proximal tubule cell. In addition, our experiments with ligand binding to semi-thin and ultra-thin cryosections and subsequent autoradiography demonstrate that these techniques are powerful tools with high resolution in studies of receptor distribution and their subcellular localization.
The dense apical tubules in the apical cytoplasm contain gp330 (Figure 4b ), as was also recently shown by Biemesderfer et al. (2) . The dense apical tubules are responsible for membrane recycling in proximal tubule cells, as shown previously with cationized ferritin (3) and recently reviewed (4.20). gp330 is not localized in lysosomes but exclusively in the initial compartment of the endocytic pathway. This suggests a general endocytosis mechanism with lysosomal degradation of the ligand and recycling of the receptor: a2MRAP is initially bound in endocytic invaginations to gp330 and the ligand-receptor complex is then internalized into endocytic vacuoles in which dissociation takes place. Whereas gp330 returns to the cell surface via dense apical tubules, a2MRAP is transported into lysosomes for further processing (Figures 7b and 8 ).
Previous studies have suggested a molecular size of gp330 larger than 330 KD. On the basis of SDS-PAGE, Gutmann et al. (7) estimated 440 KD and Raychowdhury et al. (26) reported a size larger than 440 KD. The present results show that gp330 and azMR1LRP have a similar size as estimated by SDS-PAGE.
Fixation of gp330 in SDS gels with 8% paraformaldehyde did not change the binding of azMRAP, supporting the conclusion that binding on the cryosections was to gp330. This conclusion is also strengthened by the observation that the binding was Ca2+ dependent on sections as well as on SDS gels.
We chose a2MRAP to probe the function of gp330 as a receptor for endocytic uptake because it is a ligand for the homologous a2MRILRP. and we found similarities in the binding properties. Thus, heparin blocks the binding to both receptors. EDTA blocked binding to gp330 and has been shown to release most pre-bound a2MRAP from a2MRILRP (8) . We have previously reported blotting of labeled a2MRAP to immobilized a2MR/LRP in the presence of EDTA (22), but subsequent experiments did show inhibition of binding with EDTA (unpublished observation). As shown here, gp330 is a strong binder of Ca2+, as is a2MRILRP (24). and this ion provides the conformation necessary for binding of a2M-proteinase complexes to a2MRlLRP (24).
None of the anti-gp330 antibodies appeared to bind to the ligand binding region, since no inhibition of a2MRAP binding was found. Similarly, a series of MAb against the a2MRILRP have been demonstrated not to interfere with ligand binding to a2MRILRP (23).
The abundance of gp330 in the renal cortex suggests that this protein has functions other than binding a2MRAP. As a major Ca2+-binding protein in the proximal tubule, it might be involved in the handling of filtered Ca2+. It may also serve as a receptor for several other proteins, in analogy with a2MRILRP. In fact, while this work was in progress plasminogen was reported to bind to gp330 purified by SDS-PAGE (11) . The present result, that plasminogen virtually abolished a2MRAP binding, suggests that the two ligands bind to the same domain. The functional significance of this finding remains to be established, since plasminogen should be filtered in the glomerulus only to a limited degree.
a2MRAP is abundant in kidney (8), liver, and placenta (10, 22) , and is present in fibroblasts (27). The results of pulse-chase immunoprecipitation experiments in fibroblasts show that a2MRAP remains associated with the cellular fraction (27). In addition, it has not been possible to detect a2MRAP by immunoblot analysis of conditioned medium, serum, or plasma (27; and unpublished observations). Therefore, a2MRAP is likely to occur in plasma only after cell damage, if at all. 
CHRISTENSEN, GLIEMA", MOESTRUP
Injection of recombinant azMRAP in rats can induce immune deposits in glomeruli like those seen in Heymann nephritis, a rat model for human glorulonephritis ( 2 5 ) . These deposits may originate from binding of immunoglobulin to a2MRAP associated with gp330 in rat podocytes. Such a mechanism is unlikely in humans, since human podocytes are reported not to express gp330 (14). Alternatively, deposits in glomeruli may originate from azMRAPanti-azMRAP complexes in plasma, a mechanism of possible relevance for the pathogenesis of human glomerulonephritis.
In conclusion, we have demonstrated that gp330 in renal proximal tubules is an endocytic Ca2+ binding receptor and therefore is not only structurally but also functionally related to a2MR/LRP. The functional role of gp330 in the renal handling of Ca2+ and its role in endocytosis should be studied further in biochemical experiments and possibly in isolated perfused proximal tubules. 
